0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Companion Diagnostic Market Insights, Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-27J1624
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Companion Diagnostic Market Insights Forecast to 2028

Global Companion Diagnostic Market Insights, Forecast to 2028

Code: QYRE-Auto-27J1624
Report
February 2022
110 Pages
QYResearch
Region: Global, North America, Europe, Japan, Central & South America,
Description
Table of Content
Tables & Figures
A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
Market Analysis and Insights: Global Companion Diagnostic Market

The global Companion Diagnostic market size is projected to reach US$ 32340 million by 2028, from US$ 8820 million in 2021, at a CAGR of 20.3% during 2022-2028.

Fully considering the economic change by this health crisis, Immunohistochemistry accounting for % of the Companion Diagnostic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Oncology segment is altered to an % CAGR throughout this forecast period.
China Companion Diagnostic market size is valued at US$ million in 2021, while the North America and Europe Companion Diagnostic are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Companion Diagnostic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic market.
Global Companion Diagnostic Scope and Market Size
Companion Diagnostic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Immunohistochemistry
Molecular Diagnosis

Segment by Application

Oncology
Cardiovascular
Central Nervous System
Virology
Others

BY COMPANY

Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina, Inc

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnosis
1.3 Market by Application
1.3.1 Global Companion Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Virology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Market Perspective (2017-2028)
2.2 Companion Diagnostic Growth Trends by Region
2.2.1 Companion Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Companion Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Companion Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Companion Diagnostic Market Dynamics
2.3.1 Companion Diagnostic Industry Trends
2.3.2 Companion Diagnostic Market Drivers
2.3.3 Companion Diagnostic Market Challenges
2.3.4 Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Players by Revenue
3.1.1 Global Top Companion Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Revenue
3.4 Global Companion Diagnostic Market Concentration Ratio
3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2021
3.5 Companion Diagnostic Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Breakdown Data by Type
4.1 Global Companion Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Companion Diagnostic Forecasted Market Size by Type (2023-2028)
5 Companion Diagnostic Breakdown Data by Application
5.1 Global Companion Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Companion Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Diagnostic Market Size (2017-2028)
6.2 North America Companion Diagnostic Market Size by Type
6.2.1 North America Companion Diagnostic Market Size by Type (2017-2022)
6.2.2 North America Companion Diagnostic Market Size by Type (2023-2028)
6.2.3 North America Companion Diagnostic Market Share by Type (2017-2028)
6.3 North America Companion Diagnostic Market Size by Application
6.3.1 North America Companion Diagnostic Market Size by Application (2017-2022)
6.3.2 North America Companion Diagnostic Market Size by Application (2023-2028)
6.3.3 North America Companion Diagnostic Market Share by Application (2017-2028)
6.4 North America Companion Diagnostic Market Size by Country
6.4.1 North America Companion Diagnostic Market Size by Country (2017-2022)
6.4.2 North America Companion Diagnostic Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Companion Diagnostic Market Size (2017-2028)
7.2 Europe Companion Diagnostic Market Size by Type
7.2.1 Europe Companion Diagnostic Market Size by Type (2017-2022)
7.2.2 Europe Companion Diagnostic Market Size by Type (2023-2028)
7.2.3 Europe Companion Diagnostic Market Share by Type (2017-2028)
7.3 Europe Companion Diagnostic Market Size by Application
7.3.1 Europe Companion Diagnostic Market Size by Application (2017-2022)
7.3.2 Europe Companion Diagnostic Market Size by Application (2023-2028)
7.3.3 Europe Companion Diagnostic Market Share by Application (2017-2028)
7.4 Europe Companion Diagnostic Market Size by Country
7.4.1 Europe Companion Diagnostic Market Size by Country (2017-2022)
7.4.2 Europe Companion Diagnostic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Companion Diagnostic Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Companion Diagnostic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Companion Diagnostic Market Share by Type (2017-2028)
8.3 Asia-Pacific Companion Diagnostic Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Companion Diagnostic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Companion Diagnostic Market Share by Application (2017-2028)
8.4 Asia-Pacific Companion Diagnostic Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Companion Diagnostic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Market Size (2017-2028)
9.2 Latin America Companion Diagnostic Market Size by Type
9.2.1 Latin America Companion Diagnostic Market Size by Type (2017-2022)
9.2.2 Latin America Companion Diagnostic Market Size by Type (2023-2028)
9.2.3 Latin America Companion Diagnostic Market Share by Type (2017-2028)
9.3 Latin America Companion Diagnostic Market Size by Application
9.3.1 Latin America Companion Diagnostic Market Size by Application (2017-2022)
9.3.2 Latin America Companion Diagnostic Market Size by Application (2023-2028)
9.3.3 Latin America Companion Diagnostic Market Share by Application (2017-2028)
9.4 Latin America Companion Diagnostic Market Size by Country
9.4.1 Latin America Companion Diagnostic Market Size by Country (2017-2022)
9.4.2 Latin America Companion Diagnostic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Companion Diagnostic Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Companion Diagnostic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Companion Diagnostic Market Share by Type (2017-2028)
10.3 Middle East & Africa Companion Diagnostic Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Companion Diagnostic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Companion Diagnostic Market Share by Application (2017-2028)
10.4 Middle East & Africa Companion Diagnostic Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Companion Diagnostic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Details
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostic Introduction
11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2017-2022)
11.1.5 Roche Holdings Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostic Introduction
11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction
11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostic Introduction
11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022)
11.4.5 Agilent Technologies Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Companion Diagnostic Introduction
11.5.4 Merck Revenue in Companion Diagnostic Business (2017-2022)
11.5.5 Merck Recent Developments
11.6 Agendia
11.6.1 Agendia Company Details
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Business (2017-2022)
11.6.5 Agendia Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Companion Diagnostic Introduction
11.7.4 Qiagen Revenue in Companion Diagnostic Business (2017-2022)
11.7.5 Qiagen Recent Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Details
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Companion Diagnostic Introduction
11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022)
11.8.5 Myriad Genetics Recent Developments
11.9 Advanced Cell Diagnostics
11.9.1 Advanced Cell Diagnostics Company Details
11.9.2 Advanced Cell Diagnostics Business Overview
11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction
11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022)
11.9.5 Advanced Cell Diagnostics Recent Developments
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Business (2017-2022)
11.10.5 Danaher Recent Developments
11.11 Illumina, Inc
11.11.1 Illumina, Inc Company Details
11.11.2 Illumina, Inc Business Overview
11.11.3 Illumina, Inc Companion Diagnostic Introduction
11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022)
11.11.5 Illumina, Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Immunohistochemistry
    Table 3. Key Players of Molecular Diagnosis
    Table 4. Global Companion Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Companion Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Companion Diagnostic Market Share by Region (2017-2022)
    Table 8. Global Companion Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Companion Diagnostic Market Share by Region (2023-2028)
    Table 10. Companion Diagnostic Market Trends
    Table 11. Companion Diagnostic Market Drivers
    Table 12. Companion Diagnostic Market Challenges
    Table 13. Companion Diagnostic Market Restraints
    Table 14. Global Companion Diagnostic Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Companion Diagnostic Revenue Share by Players (2017-2022)
    Table 16. Global Top Companion Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
    Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Companion Diagnostic Product Solution and Service
    Table 21. Date of Enter into Companion Diagnostic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Companion Diagnostic Revenue Market Share by Type (2017-2022)
    Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Companion Diagnostic Revenue Market Share by Type (2023-2028)
    Table 27. Global Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Companion Diagnostic Revenue Share by Application (2017-2022)
    Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Companion Diagnostic Revenue Share by Application (2023-2028)
    Table 31. North America Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Companion Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Companion Diagnostic Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Companion Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Companion Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Companion Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Companion Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Companion Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Companion Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Roche Holdings Company Details
    Table 62. Roche Holdings Business Overview
    Table 63. Roche Holdings Companion Diagnostic Product
    Table 64. Roche Holdings Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 65. Roche Holdings Recent Developments
    Table 66. Abbott Laboratories Company Details
    Table 67. Abbott Laboratories Business Overview
    Table 68. Abbott Laboratories Companion Diagnostic Product
    Table 69. Abbott Laboratories Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 70. Abbott Laboratories Recent Developments
    Table 71. Thermo Fisher Scientific Company Details
    Table 72. Thermo Fisher Scientific Business Overview
    Table 73. Thermo Fisher Scientific Companion Diagnostic Product
    Table 74. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 75. Thermo Fisher Scientific Recent Developments
    Table 76. Agilent Technologies Company Details
    Table 77. Agilent Technologies Business Overview
    Table 78. Agilent Technologies Companion Diagnostic Product
    Table 79. Agilent Technologies Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 80. Agilent Technologies Recent Developments
    Table 81. Merck Company Details
    Table 82. Merck Business Overview
    Table 83. Merck Companion Diagnostic Product
    Table 84. Merck Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 85. Merck Recent Developments
    Table 86. Agendia Company Details
    Table 87. Agendia Business Overview
    Table 88. Agendia Companion Diagnostic Product
    Table 89. Agendia Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 90. Agendia Recent Developments
    Table 91. Qiagen Company Details
    Table 92. Qiagen Business Overview
    Table 93. Qiagen Companion Diagnostic Product
    Table 94. Qiagen Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 95. Qiagen Recent Developments
    Table 96. Myriad Genetics Company Details
    Table 97. Myriad Genetics Business Overview
    Table 98. Myriad Genetics Companion Diagnostic Product
    Table 99. Myriad Genetics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 100. Myriad Genetics Recent Developments
    Table 101. Advanced Cell Diagnostics Company Details
    Table 102. Advanced Cell Diagnostics Business Overview
    Table 103. Advanced Cell Diagnostics Companion Diagnostic Product
    Table 104. Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 105. Advanced Cell Diagnostics Recent Developments
    Table 106. Danaher Company Details
    Table 107. Danaher Business Overview
    Table 108. Danaher Companion Diagnostic Product
    Table 109. Danaher Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 110. Danaher Recent Developments
    Table 111. Illumina, Inc Company Details
    Table 112. Illumina, Inc Business Overview
    Table 113. Illumina, Inc Companion Diagnostic Product
    Table 114. Illumina, Inc Revenue in Companion Diagnostic Business (2017-2022) & (US$ Million)
    Table 115. Illumina, Inc Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Companion Diagnostic Market Share by Type: 2021 VS 2028
    Figure 2. Immunohistochemistry Features
    Figure 3. Molecular Diagnosis Features
    Figure 4. Global Companion Diagnostic Market Share by Application: 2021 VS 2028
    Figure 5. Oncology Case Studies
    Figure 6. Cardiovascular Case Studies
    Figure 7. Central Nervous System Case Studies
    Figure 8. Virology Case Studies
    Figure 9. Others Case Studies
    Figure 10. Companion Diagnostic Report Years Considered
    Figure 11. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Companion Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Companion Diagnostic Market Share by Region: 2021 VS 2028
    Figure 14. Global Companion Diagnostic Market Share by Players in 2021
    Figure 15. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2021
    Figure 17. North America Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Companion Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 19. North America Companion Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 20. North America Companion Diagnostic Market Size Share by Country (2017-2028)
    Figure 21. United States Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Companion Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Companion Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Companion Diagnostic Market Size Share by Country (2017-2028)
    Figure 27. Germany Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Companion Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Companion Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Companion Diagnostic Market Size Share by Region (2017-2028)
    Figure 37. China Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Companion Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Companion Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Companion Diagnostic Market Size Share by Country (2017-2028)
    Figure 47. Mexico Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Companion Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Companion Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Companion Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Companion Diagnostic Market Size Share by Country (2017-2028)
    Figure 53. Turkey Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Companion Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 57. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 59. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 60. Merck Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 61. Agendia Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 62. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 63. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 64. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 65. Danaher Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 66. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global and United States Biologics Drug Development Market Report Forecast 2022 2028
Global and United States Biologics Drug Development Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
Global and United States Biologics Drug Discovery Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-0D6239
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Nanopharmaceutical Drugs Market Report Forecast 2022 2028
Global and United States Nanopharmaceutical Drugs Market Report & Forecast 2022-2028

The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.Market Analysis and Insights Global and United States Nanopharmaceutical Drugs MarketThis report focuses on global and United States Nanopharmaceutical Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Nanopharmaceutical Drugs market size is estimated to be worth US 35330 million in 2022 and is forecast to a readjusted size of US 72540 million by 2028 with a CAGR of 12.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24J10248
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Polymerase Chain Reaction Technology Market Report Forecast 2022 2028
Global and United States Polymerase Chain Reaction Technology Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7I6111
Tue Jun 07 00:00:00 UTC 2022

Add to Cart